Cas:38395-02-7 Caudatin manufacturer & supplier

We serve Chemical Name:Caudatin CAS:38395-02-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Caudatin

Chemical Name:Caudatin
CAS.NO:38395-02-7
Synonyms:2-Pentenoic acid, 3,4-dimethyl-, (3β,12β,14β)-3,8,14,17-tetrahydroxy-20-oxopregn-5-en-12-yl ester, (2E)-;(3β,12β,14β)-3,8,14,17-Tetrahydroxy-20-oxopregn-5-en-12-yl (2E)-3,4-dimethyl-2-pentenoate
Molecular Formula:C28H42O7
Molecular Weight:490.629
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:617.9±55.0 °C at 760 mmHg
Density:1.3±0.1 g/cm3
Index of Refraction:1.584
PSA:124.29000
Exact Mass:490.293060
LogP:4.37

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 2-Pentenoic acid, 3,4-dimethyl-, (3β,12β,14β)-3,8,14,17-tetrahydroxy-20-oxopregn-5-en-12-yl ester, (2E)- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(3β,12β,14β)-3,8,14,17-Tetrahydroxy-20-oxopregn-5-en-12-yl (2E)-3,4-dimethyl-2-pentenoate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Pentenoic acid, 3,4-dimethyl-, (3β,12β,14β)-3,8,14,17-tetrahydroxy-20-oxopregn-5-en-12-yl ester, (2E)- Use and application,(3β,12β,14β)-3,8,14,17-Tetrahydroxy-20-oxopregn-5-en-12-yl (2E)-3,4-dimethyl-2-pentenoate technical grade,usp/ep/jp grade.


Related News: Rodent preclinical studies showed that MSP-1014 displayed superior in vivo and safety profiles in mice compared to psilocybin at a range of doses, and 5-HT2A subtype activation in rats. 4-iodocinnamic acid manufacturers The review by EMA’s safety committee (PRAC) supported by experts from the Committee for Advanced Therapies (CAT) found that the viral vector was unlikely to be the cause. N-Cyano-N’-5-quinolinylguanidine suppliers Brian McNamara, currently head of GSK’s consumer healthcare division, will continue to serve as the franchise’s CEO after it breaks away from GSK in 2022, the British pharma said Thursday. Ibandronate Sodium Monohydrate vendor & factory.